Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality
NCT00854373Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Jun 2007
- Primary completion
- Apr 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of recombinant human follicle stimulating hormone in infertility (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Mean Fertilization Proportion (2PN/Oocytes Collected) at 24 hours. Started Jun 2007; status: completed.
02
Drugs
recombinant human follicle stimulating hormone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT00854373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00854373.